Alterity Therapeutics Limited

About Alterity Therapeutics Limited

Alterity Therapeutics exists to create an alternate, healthier future for people with neurodegenerative diseases by disrupting the trajectory of these debilitating conditions through innovative therapies.

Products & Services

ATH434:A lead drug candidate being developed as a first-in-class therapy to treat neurodegenerative diseases, with demonstrated efficacy in animal models of Parkinsonian disorders and currently under evaluation in clinical trials.

Specialties

Neurodegenerative disease therapies First-in-class drug development Clinical trials for Parkinsonian disorders

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Strategic Placement T: - FT: Strategic Placement	A: 20000000 MR: - FA: A$20.0 million FAN: 20000000	D: 2025-09-08 FD: 2025-09-08	2 investors
2	RT: Placement T: - FT: Placement	A: 26800000 MR: - FA: A$40.0 million FAN: 26800000	D: 2025-02-10 FD: 2025-02-10	2 investors
3	RT: Tax Incentive Refund T: - FT: Tax Incentive Refund	A: 3900000 MR: - FA: A$3.9 million FAN: 3900000	D: 2024-03-27 FD: 2024-03-27	-
4	RT: Tax Incentive Refund T: - FT: Tax Incentive Refund	A: 4740000 MR: - FA: A$4.74 million FAN: 4740000	D: 2023-08-15 FD: 2023-08-15	-

Strategic Placement Latest

2025-09-08

$20.0M

2 investors (Pro only)

Placement 2025-02-10

$26.8M

Tax Incentive Refund 2024-03-27

$3.9M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News